Patents by Inventor Isa Samuels

Isa Samuels has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Parapox B2L protein to treat cancer and modify immune responses
    Patent number: 6844000
    Abstract: A purified Parapoxvirus ovis envelope protein termed “B2L” can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response to the B2L protein.
    Type: Grant
    Filed: December 6, 2002
    Date of Patent: January 18, 2005
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Delanie Cassell, Jeffrey S. Tepper, Isa Samuels, Nathalie Dubois-Stringfellow
  • Use of Parapox B2L protein to treat cancer and modify immune responses
    Publication number: 20030109483
    Abstract: A purified Parapoxvirus ovis envelope protein termed “B2L” can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response to the B2L protein.
    Type: Application
    Filed: December 6, 2002
    Publication date: June 12, 2003
    Inventors: Delanie Cassell, Jeffrey S. Tepper, Isa Samuels, Nathalie Dubois-Stringfellow